SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 134 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,480,000 | +483.5% | 221,421 | +410.1% | 0.01% | +550.0% |
| Q1 2017 | $425,000 | -0.7% | 43,410 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $428,000 | +86.9% | 43,410 | +94.3% | 0.00% | +100.0% |
| Q3 2016 | $229,000 | +27.2% | 22,341 | +61.9% | 0.00% | 0.0% |
| Q2 2016 | $180,000 | +18.4% | 13,799 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $152,000 | +10.1% | 13,799 | -8.3% | 0.00% | 0.0% |
| Q4 2015 | $138,000 | -30.3% | 15,048 | -47.2% | 0.00% | 0.0% |
| Q3 2015 | $198,000 | – | 28,527 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athos Capital Ltd | 410,389 | $4,596,000 | 3.46% |
| GLG Partners LP | 2,586,437 | $28,968,000 | 1.54% |
| Nine Chapters Capital Management LLC | 32,300 | $362,000 | 0.80% |
| FNY Partners Fund LP | 335,900 | $3,762,000 | 0.64% |
| MENTA CAPITAL LLC | 373,523 | $4,183,000 | 0.61% |
| Yakira Capital Management, Inc. | 85,500 | $958,000 | 0.32% |
| Sapphire Star Partners LP | 18,724 | $209,000 | 0.27% |
| GAM Holding AG | 541,025 | $6,059,000 | 0.26% |
| Bowling Portfolio Management LLC | 127,873 | $1,432,000 | 0.22% |
| Kassirer Asset Management Corp | 15,000 | $168,000 | 0.16% |